Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.6

-0.42

-0.25

-0.07

Details

Expected EPS

-0.11

Actual EPS

-0.6

Surprise EPS

-0.49

Surprise Percent

+445.45%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.6 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.